Technology is more critical than ever to help you keep your clinical trials on track during the era of COVID-19. Gain best practices about how to empower your remote workforce, get critical regulated documents electronically signed compliantly, and to create a safe and flexible remote patient-centric experience. Live: Wednesday, Jul. 15, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until Jul. 15, 2021. Register free
Register free: http://www.pharmtech.com/pt_w/development_to_trials
Event Overview:
The COVID-19 pandemic has drastically altered the life sciences industry as global travel restrictions and stay-at-home orders have impacted the ability drug companies to continue ‘as usual’ to get drugs to market. Despite these changes, the development, clinical trials, and manufacturing of therapies still need to hit critical deadlines while ensuring that regulated documents are compliant.
Learn best practices about how to implement effective technological solutions to digitize aspects the pharmaceutical value chain. A key topic will be how to quickly and efficiently attain internal and external signatures that are compliant with the FDA’s 21 Code of Federal Regulations Part 11 regulations and allow trial flexibility such as remotely enrolling patients into clinical trials.
Key Learning Objectives:
Speakers: Ellen Reilly, VP, Global Partners, IQVIA
Kirsten Schaub, AVP - Commercial Sales, Healthcare and Life Sciences, DocuSign
Christina S. Wong, Marketing – Regulated Industries, DocuSign
Time and Date: Wednesday, Jul. 15, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
On demand available after airing until Jul. 15, 2021.
Sponsor: DocuSign
Register free: http://www.pharmtech.com/pt_w/development_to_trials